Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients

NCT01013987 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Adults Patients
AIDS
Triple Class Failure

Interventions

DRUG: maraviroc
DRUG: Raltegravir
DRUG: Darunavir/ritonavir

Sponsor

Fundación Huésped

Collaborators

[object Object]